Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Ivantis
company
About
Ivantis is focused on developing an innovative treatment for glaucoma which includes eye drops, laser therapy, and surgery.
- 101 - 250
Highlights
Details
- Last Funding Type
- Series B
- Last Funding Money Raised
- $25M
- Industries
- Health Care,Health Diagnostics,Medical Device
- Founded date
- Jan 1, 2007
- Number Of Employee
- 101 - 250
- Operating Status
- Active
Ivantis, Inc. is a company focused on developing an innovative treatment for Glaucoma. It is their goal to develop a less invasive, more effective option for the 60+ million people worldwide suffering from Primary Open Angle Glaucoma. As they successfully address this initial goal, it is then there intention to focus on innovative development for the treatment of other debilitating diseases within ophthalmology.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$25M
Ivantis has raised a total of
$25M
in funding over 2 rounds. Their latest funding was raised on
Sep 23, 2014 from a Series B round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Sep 23, 2014 | Series B | $25M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
1
Ivantis is funded by 1 investors.
Versant Ventures
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Versant Ventures
|
— | Series B |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
